VXRTMICRO

Vaxart, Inc.

HealthcareBiotechnology
$0.57
$0.00(+5.28%)
52W$0.26
$0.84
Updated Jun 30, 02:00 AM
RSI40
RS Rating63/99
Beta0.56
Volatility100%
F-Score7/9
Mkt Cap$137M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Vaxart, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 63), indicating performance broadly in line with the market. Earnings growth of 129% provides fundamental context to the price action. Investors should exercise caution due to high volatility (100% annualized), which requires wider risk management.

Relative Strength
63
out of 99
Average
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.56
vs S&P 500
DEFENSIVE
52W Position
53%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$0.65
50 SMA > 100 SMA$0.66
100 SMA > 150 SMA$0.59
150 SMA > 200 SMA$0.54

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$0.57-0.60%BELOW
50 SMA$0.65-12.74%BELOW
100 SMA$0.66-13.47%BELOW
150 SMA$0.59-4.09%BELOW
200 SMA$0.54+6.05%ABOVE

Price Performance

1D+5.3%
1W+7.2%
1M-13.9%
3M-2.9%
6M+62.3%
YTD+57.8%
1Y+25.7%
3Y-9.3%
52-Week Trading Range53% from low
$0.57
52W Low$0.26
52W High$0.84

Technical Indicators

RSI (14)NEUTRAL
40.0
305070
Setup ScoreCOOL
3/10
Base depth: 53.0%

Risk Profile

Beta
0.56
52W Vol
100%
ATR
$0.04
Max DD (1Y)
-44%

Volume Analysis

Today
109.5K
50D Avg
163.4K
Vol Ratio
0.67x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25-107%
$-0.07
Q3'25-38%
$-0.04
Q4'25+537%
$0.23
Q1'26+129%
$0.02
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+38.25%
5 Years:+125.76%
3 Years:+12.04%
TTM:+439.32%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+176.21%

Stock Price CAGR

10 Years:-28.26%
5 Years:-41.44%
3 Years:-9.25%
1 Year:+25.66%

Return on Equity

10Y Avg:-84.5%
5Y Avg:-61.6%
3Y Avg:-63.5%
Last Year:61.4%

Key Metrics

Market Cap$137M
Gross Margin1.0%
Net Margin6.9%
Piotroski F-Score7/9

Frequently Asked Questions

Is VXRT in an uptrend right now?

VXRT has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is VXRT overbought or oversold?

VXRT's RSI (14) is 40. The stock is in neutral territory, neither overbought nor oversold.

Is VXRT outperforming the market?

VXRT has a Relative Strength (RS) Rating of 63 out of 99. VXRT is performing about average compared to the market.

Where is VXRT in its 52-week range?

VXRT is trading at $0.57, which is 68% of its 52-week high ($0.84) and 53% above its 52-week low ($0.26).

How volatile is VXRT?

VXRT has a Beta of 0.56 and 52-week volatility of 100%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.